Surveys of Transmitted HIV Drug Resistance in 7 Geographic Regions in China, 2008–2009
Open Access
- 15 May 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 54 (suppl_4), S320-S323
- https://doi.org/10.1093/cid/cir1016
Abstract
In 2003, antiretroviral therapy became available free of charge in China’s public health sector. During 2008 and 2009, 10 surveys to classify transmitted human immunodeficiency virus drug resistance (HIVDR) were conducted in 7 regions in 5 provinces (autonomous regions and municipalities) according to World Health Organization guidance. In 2008, transmitted HIVDR was classified as low (<5%) to nucleoside reverse-transcriptase inhibitors, nonnucleoside reverse-transcriptase inhibitors, and protease inhibitors in 6 surveys performed in 6 regions. In 2009, 3 of 4 surveys showed low rates of transmitted HIVDR to all drug classes, and 1 survey showed moderate (5%–15%) rates of transmitted protease inhibitor resistance. In China, routine surveillance of transmitted HIVDR should continue and be expanded to other regions of the country.Keywords
This publication has 10 references indexed in Scilit:
- Surveillance of Transmitted HIV Type 1 Drug Resistance in Newly Diagnosed HIV Type 1-Infected Patients in Shandong Province, ChinaAIDS Research and Human Retroviruses, 2010
- The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistanceBioinformatics, 2009
- Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 UpdatePLOS ONE, 2009
- The Effect of Highly Active Antiretroviral Therapy on Mortality among HIV‐Infected Former Plasma Donors in ChinaClinical Infectious Diseases, 2008
- Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatmentAntiviral Therapy, 2008
- A novel sequential sampling technique for the surveillance of transmitted HIV drug resistance by cross-sectional survey for use in low resource settingsAntiviral Therapy, 2008
- Genetic Diversity and Drug Resistance of Human Immunodeficiency Virus Type 1 (HIV-1) Strains Circulating in ShanghaiAIDS Research and Human Retroviruses, 2007
- Web Resources for HIV Type 1 Genotypic-Resistance Test InterpretationClinical Infectious Diseases, 2006
- Full-Length Human Immunodeficiency Virus Type 1 Genomes from Subtype C-Infected Seroconverters in India, with Evidence of Intersubtype RecombinationJournal of Virology, 1999